边缘带来墨水
发表于 2025-3-28 17:21:39
Predictive and Prognostic Markers in Metastatic Renal Cell Carcinoma,were identified as key prognostic features. Patients were segregated into three risk categories: favorable (0 risk factors median overall survival (mOS) of 43.2 months), intermediate (one to two risk factors; mOS 22.5 months), and poor risk group (three or more risk factors; mOS 7.8 months). Also th
Asseverate
发表于 2025-3-28 18:57:59
Mammalian Targets of Rapamycin Inhibitors: Temsirolimus and Everolimus,ent settings, yielding conflicting results. Further development of these two drugs in renal cell carcinoma is expected, even though only the identification of reliable genetic or molecular biomarkers will lead to a tailored, and thus smarter, use of these drugs.
格子架
发表于 2025-3-28 23:49:19
http://reply.papertrans.cn/83/8270/826987/826987_43.png
Blood-Clot
发表于 2025-3-29 05:46:45
http://reply.papertrans.cn/83/8270/826987/826987_44.png
禁止,切断
发表于 2025-3-29 08:38:21
Book 2017ndocrine tumors of pancreatic origin and to breast cancer, suggesting that RCC is no longer an "orphan disease" in the field of molecular oncology. Additional topics covered in the book include pharmacokinetics and pharmacodynamics in molecular-targeted agents and the putative mechanism of resistanc
机密
发表于 2025-3-29 14:11:37
http://reply.papertrans.cn/83/8270/826987/826987_46.png
colony
发表于 2025-3-29 18:37:20
Jaimin R. Bhatt,Patrick O. Richard,Michael A. S. Jewett method which most textbooks do not cover, but is valuable in actual practice. In the end, the user is ready to use both the design methodology and the basic computing building blocks presented in the book to 978-3-319-25811-9
清澈
发表于 2025-3-29 21:09:44
http://reply.papertrans.cn/83/8270/826987/826987_48.png
Gobble
发表于 2025-3-30 02:47:28
http://reply.papertrans.cn/83/8270/826987/826987_49.png
Palliation
发表于 2025-3-30 07:26:10
https://doi.org/10.1007/978-4-431-55531-5Molecular-targeted therapy; TKI; anti-angiogenic agent; mTOR inhibitors; tyrosine-kinase inhibitors